Gary Jennings

This inventor holds 13 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Gri Bio, Inc., Jado Technologies Gmbh, Glycoregimmune, Inc.. Active years: 2009-2026.

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 76.9

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

Jado Technologies Gmbh

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

5. 1 out of 100

Technische Universitát Dresden

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528775 - Oxygenated and amino- or ammonium-containing phosphonic acid derivatives and their medical use (2026-01-20),

2. 11564895 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2023-01-31),

3. 11453642 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2022-09-27),

4. 10952977 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2021-03-23),

5. 10829506 - Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2020-11-10),

6. 10815195 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2020-10-27),

7. 10143668 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2018-12-04),

8. 9850265 - Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2017-12-26),

9. 9751834 - Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use (2017-09-05),

10. 9573886 - Hydroxy-substituted amino and ammonium derivatives and their medical use (2017-02-21),

11. 8394785 - Methods for the treatment and amelioration of urticaria (2013-03-12),

12. 7998945 - Methods for the treatment and amelioration of atopic dermatitis (2011-08-16),

13. 7629385 - Sphingolipid-derived pharmaceutical compositions (2009-12-08),

Title: Gary Jennings: Innovator in Medical Chemistry

Introduction

Gary Jennings is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of medical chemistry, holding a total of 13 patents. His work focuses on developing innovative compounds that have potential medical applications.

Latest Patents

Among his latest patents, Jennings has developed hydroxy-substituted amino and ammonium derivatives. These compounds are particularly relevant for their medical use in treating, preventing, or ameliorating inflammatory, autoimmune, and allergic disorders, as well as proliferative, neoplastic, or dysplastic diseases. Another notable patent involves oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid, and carboxylic acid derivatives. Similar to his previous work, these compounds are aimed at addressing various medical conditions.

Career Highlights

Throughout his career, Jennings has worked with several companies, including Gri Bio, Inc. and Jado Technologies GmbH. His expertise in medical chemistry has allowed him to contribute to various innovative projects and advancements in the field.

Collaborations

Gary Jennings has collaborated with notable professionals in his field, including Tim Friedrichson and Tobias Braxmeier. These collaborations have further enhanced his research and development efforts.

Conclusion

In summary, Gary Jennings is a distinguished inventor whose work in medical chemistry has led to the development of important compounds with significant therapeutic potential. His contributions continue to impact the medical field positively.